CURRICULUM VITAE of TUNDE PETO 21St March 2013

Total Page:16

File Type:pdf, Size:1020Kb

CURRICULUM VITAE of TUNDE PETO 21St March 2013 Tunde Peto CURRICULUM VITAE OF TUNDE PETO 21st March 2013 Name: Tunde Peto, MD, MHealthEd, PhD Work address: Reading Centre, Department of Research and Development Moorfields Eye Hospital, NHS Foundation Trust City Road, London, EC1V 2PD Tel: 0207 566 2815; Fax: 0207 608 6925 E-mail: [email protected] Degrees held: Medical Doctor, Albert Szent-Györgyi Medical University, 1990, Hungary Master of Health Education, Attila József University, 1991, Hungary Doctor of Philosophy, University of Newcastle, 1998, Australia Final Exam in Ophthalmology: 2000, Hungarian Exam Board Registration: Full registration with specialist registration as ophthalmologist in the United Kingdom: 6036859 Full registration in Hungary: 48283 Clinically qualified with valid specialist registration Clinically active as medical retina specialist at Moorfields Eye Hospital Current appointments: Visiting Reader, University of Surrey Head of Reading Centre and Medical Retina Specialist Moorfields Eye Hospital NHS Foundation Trust NIHR BMRC Fellow in Ophthalmology at the Institute of Ophthalmology, University College London and Moorfields Eye Member of BMRC Clinical Lead of the Tower Hamlets PCT Diabetic Retinopathy Screening Service, Diabetes Centre, Mile End Hospital Employment history: 1990 – 1992 Junior registrar, Albert Szent-Györgyi Medical University, Hungary 1991 Visiting junior registrar, University of Padova, Italy 1993 – 1994 Junior Lecturer at University of Newcastle, Australia 1994-1997 PhD student, University of Newcastle, Australia 1998 – 2000 Senior registrar, Albert Szent-Györgyi Medical University, Hungary 2000 - 2001 Lecturer, Albert Szent-Györgyi Medical University, Hungary 2001 – Present Head of Reading Centre and Medical Retina Specialist at Moorfields Eye Hospital NHS Foundation Trust and NIHR BMRC Fellow in Ophthalmology at the Institute of Ophthalmology, University College London and Moorfields Eye Grants attracted in the past 3 years 2013 – 2016 CREST and TILDA: about £56 000 altogether for 3 years 20012 – 2015 STRONG – FP7 EU Grant; £35000/year Tunde Peto 2009 – 2013 MERLOT RCT; £20000/year 2009-2013 ORAYA RCT; £40000/year 2009-2011 Hungarian Technology Grant 335 000000 forints (£100 000) 2006 - 2016 MacTel Study: £250000/year 2008 - 2010 Solvay-Quintiles Drug trial Reading Centre component £128000 2007 Nigeria Low Vision Survey Reading Centre Funding: via London School of Hygiene and Tropical Medicine Funding: £5000 2007 - 2008 Avastin in Diabetic Macular Oedema RCT Reading Centre Funding: Special Trustees of Moorfields Eye Hospital Funding 2007 - 2008 WHO Onchocerciasis Project Reading Centre Funding: WHO Funding: £50/patient 2007 Nidek Italy Automated Image Analysis Software Reading Centre Fund: NIDEK Italy Industry Funding: £3000 2007 - 2010 Kenya Eye Study Reading Centre Funding: £10000 2007 - 2009 Allergan Education Grant for Dry Eye Reading Standards Funding: £25000 2006 – 2012 IVAN RCT Reading Centre Funding: Department of Health Funding: In Excess of £100000 2004 - 2009 VPDT Cohort Study UK Funding: Department of Health: In excess of £400000 Memberships of learned societies EASDec – Secretary ARVO – Programme Board Member EVI – Head of Reading Centre Committee UK National Screening Committee – Deputy Chair for Training, Education and Workforce Last 3 year’s referred publications Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR; Macular Telangiectasia Project Research Group.Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic Epidemiol. 2013 Apr;20(2):109-13. Mathenge W, Bastawrous A, Peto T, Leung I, Foster A, Kuper H. Prevalence of age-related macular degeneration in nakuru, kenya: a cross-sectional population-based study. PLoS Med. 2013 Feb;10(2):e1001393. doi: 10.1371/journal.pmed.1001393. Epub 2013 Feb 19. Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin P. Diabetic retinopathy: Pathogenesis, Clinical Grading, Management And Future Developments. Diabet. Med. 2012 Dec 4. [Epub ahead of print]. Pathai S, Weiss HA, Lawn SD, Peto T, D'Costa LM, Cook C, Wong TY, Gilbert CE.Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV? PLoS One. 2012;7(12):e51405. doi: 10.1371/journal.pone.0051405. Epub 2012 Dec 10. Tunde Peto Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren T, Peto T, Holz FG, Scholl HPN. Macular Telangiectasia Type 2. Prog Retin Eye Res. 2012 Dec 3. [Epub ahead of print]. Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, Sjølie AK, Njølstad I. Tromsø Eye Study: Prevalence And Risk Factors of Diabetic Retinopathy. Acta Ophthalmol. 2012 Sep 20. [Epub ahead print]. Bertelsen G, Erke MG, Von Hanno T, Mathiesen EB, Peto T, Sjølie AK, Njølstad, I. The Tromsø Eye Study: Study Design, Methodology And Results On Visual Acuity And Refractive Errors. Acta Ophthalmol. 2012 Sep 11. [Epub ahead of print]. Erke MG, Bertelsen G, Peto T, Sjølie AK, Lindekleiv H, Njølstad I. Prevalence Of Age-Related Macular Degeneration In Elderly Caucasians: The Tromsø Eye Study. Ophthalmology. 2012 Sep;119(9):1737–43. Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG. A 2-Year Prospective Randomized Controlled Trial Of Intravitreal Bevacizumab Or Laser Therapy (BOLT) In The Management Of Diabetic Macular Edema: 24-Month Data: Report 3. Arch. Ophthalmol. 2012 Aug 1;130(8):972–9. Sallo FB, Leung I, Mathenge W, Kyari F, Kuper H, Gilbert CE, Bird AC, Peto T. The Prevalence Of Type 2 Idiopathic Macular Telangiectasia In Two African Populations. Ophthalmic Epidemiol. 2012 Aug;19(4):185–9. Peto T, Tadros C. Screening For Diabetic Retinopathy And Diabetic Macular Edema In The United Kingdom. Curr. Diab. Rep. 2012 Aug;12(4):338–45. Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Wordsworth S, Reeves BC. Ranibizumab Versus Bevacizumab To Treat Neovascular Age-Related Macular Degeneration: One-Year Findings From The IVAN Randomized Trial. Ophthalmology. 2012 Jul;119(7):1399–411. Sofat R, Casas JP, Webster AR, Bird AC, Mann SS, Yates JRW, Moore AT, Sepp T, Cipriani V, Bunce C, Khan JC, Shahid H, Swaroop A, Abecasis G, Branham KE, Zareparsi S, Bergen AA, Klaver CCW, Baas DC, Zhang K, Chen Y, Gibbs D, Weber BHF, Keilhauer CN, Fritsche LG, Lotery A, Cree AJ, Griffiths HL, Bhattacharya SS, Chen LL, Jenkins SA, Peto T, Lathrop M, Leveillard T, Gorin MB, Weeks DE, Ortube MC, Ferrell RE, Jokobsdottir J, Conley YP, Rahu M, Seland JH, Soubrane G, Topuzis F, Vioque J, Tomazzoli L, Young I, Whittaker J, Chakravarthy U, de Jony PTVM, Smeeth L, Fletcher A, Hingorani AD. Complement Factor H Genetic Variant And Age-Related Macular Degeneration: Effect Size, Modifiers And Relationship To Disease Subtype. Int J Epidemiol. 2012 Feb;41(1):250–62. Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC and the MacTel Study Group. ‘En Face’ OCT Imaging Of The IS/OS Junction Line In Type 2 Idiopathic Macular Telangiectasia. Invest. Ophthalmol. Vis. Sci. 2012;53(10):6145–52. Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC and the MacTel Study Group. The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia. Invest. Ophthalmol. Vis. Sci. 2012;53(12):7889–95. Reeves BC, Harding SP, Langham J, Grieve R, Tomlin K, Walker J, Guerriero C, Carpenter J, Patton WP, Muldrew KA, Peto T, Chakravarthy U. Verteporfin Photodynamic Therapy For Neovascular Age-Related Macular Degeneration: Cohort Study For The UK. Health Technol Assess. 2012;16(6):i–xii, 1–200. Pathai S, Weiss HA, Lawn SD, Peto T, D’Costa LM, Cook C, Wong TY, Gilbert CE. Retinal Arterioles Narrow with Increasing Duration of Anti-Retroviral Therapy in HIV Infection: A Novel Estimator of Vascular Risk in HIV? PLoS ONE. 2012;7(12):e51405. Tunde Peto Parmalee NL, Schubert C, Figueroa M, Bird AC, Peto T, Gillies MC, Bernstein PS, Kiryluk K, Terwilliger JD, Allikmets R and the MacTel Study Group. Identification Of A Potential Susceptibility Locus For Macular Telangiectasia Type 2. Plos ONE. 2012;7(8):e24268. Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UEK, Dubra A, Williams DR, et al. Retinal Crystals In Type 2 Idiopathic Macular Telangiectasia. Ophthalmology. 2011 Dec;118(12):2461–7. Antal B, Lazar I, Hajdu A, Torok Z, Csutak A, Peto T. Evaluation of the grading performance of an ensemble-based microaneurysm detector. Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:5943-6. Piermarocchi S, Segato T, Scopa P, Masetto M, Ceca S, Cavarzeran F, Peto T; PAMDI Study Group.The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol. 2011 Jun;18(3):129-36. Parmalee NL, Schubert C, Merriam JE, Allikmets K, Bird AC, Gillies MC, Peto T, Figueroa M, Friedlander M, Fruttiger M, Greenwood J, Moss SE, Smith LE, Toomes C, Inglehearn CF, Allikmets R.Analysis of candidate genes for macular telangiectasia type 2. Mol Vis. 2010 Dec 14;16:2718-26. Mann SS, Rutishauser-Arnold Y, Peto T, Jenkins SA, Leung I, Xing W, Bird AC, Bunce C, Webster AR.The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD). Graefes Arch Clin Exp Ophthalmol. 2010 Aug 25. Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, Johnston R, Bunce C, Xing W; ABC Trial Investigators.Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ. 2010 Jun 9;340:c2459. Csutak A, Lengyel I, Jonasson F, Leung I, Geirsdottir A, Xing W, Peto T. Agreement between image grading of conventional (45°) and ultra wide-angle (200°) digital images in the macula in the Reykjavik eye study.
Recommended publications
  • Geriatric Medicine
    Programme Programme identifier – F1 Trust Site F1-1 F1-2 F1-3 Programme identifier – F2 Trust Site F2-1 F2-2 F2-3 Type Barking, Havering and Redbridge Gastroenterology - (Medicine) [Acute] {KING GEORGE Geriatric Medicine - (Medicine) [Acute] {KING GEORGE General Surgery - (Surgery) [Acute] {KING GEORGE NEWHAM GENERAL HOSPITAL Emergency Medicine - (Other) [Acute] {NEWHAM Obstetrics and Gynaecology - (Other) [Acute] {NEWHAM Cardiology - (Medicine) [Acute] {NEWHAM GENERAL Standard 20/LDN/BHRKG/F1/001 KING GEORGE HOSPITAL (RF4DG) 21/LDN/BHNEW/F2/007 BARTS HEALTH NHS TRUST University Hospitals NHS Trust HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/018} HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/006} HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/003} (R1HNH) GENERAL HOSPITAL (R1HNH) LDN/R1HNH/FND/FY2/012} GENERAL HOSPITAL (R1HNH) LDN/R1HNH/FND/FY2/025} HOSPITAL (R1HNH) LDN/R1HNH/FND/FY2/005} Geriatric Medicine - (Medicine) [Acute] {HOMERTON Emergency Medicine - (Other) [Acute] {HOMERTON Barking, Havering and Redbridge General Surgery - (Surgery) [Acute] {KING GEORGE Gastroenterology - (Medicine) [Acute] {KING GEORGE Geriatric Medicine - (Medicine) [Acute] {KING GEORGE HOMERTON UNIVERSITY HOSPITAL HOMERTON UNIVERSITY General Practice - (Other) [Community] {Homerton - Standard 20/LDN/BHRKG/F1/002 KING GEORGE HOSPITAL (RF4DG) 21/LDN/HOMFT/F2/021 UNIVERSITY HOSPITAL (RQXM1) UNIVERSITY HOSPITAL (RQXM1) University Hospitals NHS Trust HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/003} HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/018} HOSPITAL (RF4DG) LDN/RF4DG/FND/FY1/006} NHS FOUNDATION TRUST HOSPITAL
    [Show full text]
  • Common Eye Condition Management
    Common eye condition management Introduction by Moorfields’ medical director Thank you for taking the time to read this concise advice booklet about common eye conditions. It has been produced by clinicians and other staff CONTENTS at Moorfields to help you to make informed clinical decisions about your Introduction by Moorfields’ patients’ eye conditions locally, and medical director ......................... 3 avoid them having to attend hospital unnecessarily. Schematic diagram of the human eye ........................ 4 For each of the most common conditions you might see in your practice, we have listed signs and symptoms, General information Equipment and drugs to keep the equipment you will need to examine the patient, and at hand in the surgery ............ 4 the procedure to follow in undertaking that examination. General good practice advice ..................................... 5 Towards the end of the booklet, we have included a Eye examination .................... 5 table divided into four levels of urgency for onward referral – immediate, within 24 hours, within one week Care pathways for common and routine – with a list of relevant circumstances and eye conditions: conditions for each. Conjuntivitis ........................... 6 Dry eyes ............................... 7 We have also provided a table of the several locations Blepharitis ............................. 8 in which Moorfields provides care in and around Chalazion (meibomian cyst) ...10 London, and the sub-specialty services we offer in Stye .......................................11 each place. Corneal abrasion ....................12 Corneal foreign body ..............13 Subtarsal foreign body ..........14 I hope you find this guide helpful, and welcome your Subconjunctival views on how we might improve future editions. Please haemorrhage .........................15 contact our GP liaison manager on 020 7253 3411, Episcleritis .............................16 ext 3101 or by email to [email protected] with your comments.
    [Show full text]
  • BHR AHD Report V1 20130717.Doc 1
    Health Services Caring for Adults with Haemoglobin Disorders East London Barking, Havering and Redbridge University Hospitals NHS Trust Visit Date: February 5th 2013 Report Date: July 2013 BHR AHD Report V1 20130717.doc 1 CONTENTS Introduction ............................................................................................................................................................ 3 Acknowledgements ................................................................................................................................................. 3 Adult Haemoglobin Disorders Services in East London Network ............................................................................ 3 Review Visit Findings ............................................................................................................................................... 6 Appendix 1: Membership of the Review Team ..................................................................................................... 10 Appendix 2: Compliance with Quality Standards .................................................................................................. 11 BHR AHD Report V1 20130717.doc 2 INTRODUCTION This report presents the findings of the peer review visit to services for adults with sickle cell disease and thalassaemia in Barking, Havering and Redbridge University Hospitals NHS Trust, Queens Hospital, in the East London Network which took place on February 5th 2013. The purpose of the visit was to review compliance with the ‘Quality Standards
    [Show full text]
  • Barts Health Nhs Trust Pharmacy Clinical Trials Information for Sponsors Pack
    BARTS HEALTH NHS TRUST PHARMACY CLINICAL TRIALS INFORMATION FOR SPONSORS PACK Dear: Date: Thank you for considering/choosing to conduct your clinical trial at our facility. The purpose of this information pack is to support understanding of local processes for pharmacy setup of clinical trials involving investigational medicinal products (CTIMPs), IMP management and other related activities for all sites within Barts Health NHS Trust. We encourage you to raise any queries with the pharmacy clinical trials team regarding the processes outlined in this pack prior to site initiation. Otherwise acknowledgement of this pack will be taken as acceptance of the clinical trials pharmacy processes at Barts Health NHS Trust. 1. Barts Health NHS Trust Barts Health NHS Trust has a long history of research excellence and collaboration in the conduct of clinical trials. This includes strong partnerships with Queen Mary University London and the National Institute for Health Research - as well as charitable, national and international organisations. Barts Health NHS Trust consists of the following hospitals - St Bartholomew’s, Royal London, Whipps Cross, Mile End and Newham. 2. Pharmacy Clinical Trials Team The Pharmacy Clinical Trials Department at Barts Health NHS Trust is an established service delivering high quality pharmaceutical research in accordance with Good Clinical Practice (GCP) and the EU Clinical Trials Directive. The team consists of dedicated staff including specialist clinical trial pharmacists, pharmacy technicians and assistants. Staff receive training in GCP and have relevant experience in the management of clinical trials and compliance with GCP. Please see Appendix A for the Pharmacy Clinical Trials Team contact details at each site.
    [Show full text]
  • Diabetes Care Centre Mile End Hospital
    DIABETES RAMADAN SESSION Come join the Diabetes Team and learn about how to fast safely during the Ramadan month with information about healthy eating, medication and much more. (Patients only, family members welcome) Date: 9th May 2017 Start Time: 2pm - 4pm English Session Date: 16th May 2017 Start Time: 2pm - 4pm Bengali Session Date: 23rd May 2017 Start Time: 2pm - 4pm Bengali Session DIABETES CARE CENTRE MILE END HOSPITAL 2nd Floor, Bancroft Road, London E1 4DG Should you have any queries, please call the Diabetes Education Team on: 020 8223 8609 or 020 8223 8836 DIABETES RAMADAN SESSION Come join the Diabetes Team and learn about how to fast safely during the Ramadan month with information about healthy eating, medication and much more. (Patients only, family members welcome) Date: 17th May 2017 Start Time: 2pm - 4pm Bengali Session ELM, Room 306 Date: 22nd May 2017 Start Time: 10am - 12noon Bengali Session ELM, Room 304 EAST LONDON MOSQUE 46-92 Whitechapel Road, London E1 1JX Should you have any queries, please call the Diabetes Education Team on: 020 8223 8609 or 020 8223 8836 DIABETES RAMADAN SESSION Come join the Diabetes Team and learn about how to fast safely during the Ramadan month with information about healthy eating, medication and much more. (Patients only, family members welcome) WHITECHAPEL HEALTH CENTRE (Bengali Session) Date: Tuesday, 2nd May 2017 (Shah Jalal Medical Centre) Time: 2.00pm – 4.00pm 44 Hessel Street, London E1 2LP HARFORD HEALTH CENTRE (Bengali Session) Date: Tuesday, 9th May 2017 115 Harford Street, London E1 4FG Time: 10am – 12noon CHRISP STREET HEALTH CENTRE (Bengali Session) Date: Wednesday, 10th May 2017 100 Chrisp Street, London E14 6PG Time: 2.00pm – 4.00pm BLITHEHALE MEDICAL CENTRE (Bengali Session) Date: Thursday, 11th May 2017 22 Dunbridge Street, London E2 6JA Time: 10.00am – 12noon Should you have any queries, please call the Diabetes Education Team on: 020 8223 8609 or 020 8223 8836.
    [Show full text]
  • Developing the Clinical Case for Change
    Transforming Services, Changing Lives Interim Case for Change 1 A journey to improve services for the whole community We are here Publish final Case for Change Around 150 Engage with Produce Case for Local clinicians further 1,500 staff Change (not communities developed an and public solutions) and interim Case for explore and agree Change joint priorities to Patient improve local reps services Local clinicians & healthcare staff April-June July - Sept Oct onwards The programme will: • describe the current state of services • identify if change is needed to improve services for patients • begin to develop a shared vision of how we can improve services 2 The organisations involved • Newham Waltham Forest • Barts Health and east • Tower Hamlets • Homerton London Clinical • Waltham Forest Commissioning Acute trusts Groups (CCGs) Patient and Public Reference Group (PPRG), consisting of representatives from Healthwatch, hospital and CCG patient groups Community and Other • NHS England mental health commissioners • East London trusts • Barking and Dagenham CCG Foundation Trust • City and Hackney • North East CCG London • Redbridge CCG Foundation Trust • Local authorities 3 How we worked • Six Clinical Working Groups (CWGs) • Clinical Reference Group (CRG) to consider overarching clinical and demographic issues • A Patient and Public Reference Group • The programme sits alongside other CCG initiatives including integrated care, mental health and primary care transformation 4 Inpatient bed sites Homerton Whipps Cross General hospital (500 beds)
    [Show full text]
  • Barts Health NHS Trust Newham University Hospital Quality Report
    Barts Health NHS Trust Newham University Hospital Quality report Glen Road, Plaistow, London, E13 8SL Date of inspection visit: Telephone: 020 7476 4000 5-6, 11 and 14 November 2013 www.bartshealth.nhs.uk Date of publication: Janaury 2014 Overall summary Newham University Hospital is in Plaistow, East London, Our most recent inspection was in June 2013, when we and serves the people of Newham and other areas. It visited the stroke ward and an elderly ward to check that provides a full range of inpatient, outpatient and day the trust had taken action to address issues identified care services as well as maternity and accident and in August 2012. We issued two compliance actions and emergency departments. It also has a dedicated stroke asked the trust to provide us with an action plan showing unit for rehabilitation following initial urgent treatment. how they would address the shortfalls. As part of this The area the hospital serves has the third most deprived November 2013 inspection, we assessed whether the local authority (out of 326 local authorities) and has trust had addressed the shortfalls, and we took a broader been identified as one of the top 50 most deprived areas look at the quality of care and treatment in a number of in the country. departments to see if the hospital was safe, effective, Newham University Hospital is part of Barts Health NHS caring, responsive to people’s needs and well-led. Trust (the trust). Barts Health is the largest NHS trust Our inspection team included CQC inspectors and in England.
    [Show full text]
  • Upload-My-Data File Specification
    DAHNO database Upload-My-Data file specification Version: 1.4 document dated 05 Jan 2017 Author: Robin Kinsman [email protected] DAHNO 2015 Upload-My-Data file specification Glossary Glossary of terms and definitions Field separator The Field Separator is a character that is used to separate the values between fields. Any suitable character may be used, as long as it does not occur in any of the defined field values. The recommended field separator is a TAB character, although punctuation characters like a vertical bar or a caret may also be used. We recommend that files do not use a comma as a field separator as this can cause problems, such as when saving files into a text format from an Excel file. Multi-choice separator The Multi-choice Separator (MCS) is a character that is used to separate values within a multi-choice field, which may contain one or more coded values. This separator should be included in the first column of each row of every upload file. The separator may be a vertical bar, a semi-colon, a caret, etc. as long as it is a character that will not occur in any of the multi-choice codes for any field and is different from the field separator. We recommend that files do not use a comma as a field separator as this can cause problems, such as when saving files into a text format from an Excel file. Layout specification version The Layout Specification Version is the version of layout defined by this specification.
    [Show full text]
  • Moorfields Eye Hospital NHS Foundation Trust
    Moorfields Eye Hospital NHS Foundation Trust Quality Report 162 City Road, London EC1V 2PD Date of inspection visit: 9 - 13 May 2016 Tel: 020 7253 3411 Date of publication: This is auto-populated when the Website: www.moorfields.nhs.uk/ report is published This report describes our judgement of the quality of care at this trust. It is based on a combination of what we found when we inspected, information from our ‘Intelligent Monitoring’ system, and information given to us from patients, the public and other organisations. Ratings Overall rating for this trust Good ––– Are services at this trust safe? Requires improvement ––– Are services at this trust effective? Good ––– Are services at this trust caring? Good ––– Are services at this trust responsive? Requires improvement ––– Are services at this trust well-led? Good ––– 1Moorfields Eye Hospital NHS Foundation Trust Quality Report This is auto-populated when the report is published Summary of findings Letter from the Chief Inspector of Hospitals This was the first inspection of Moorfields Eye Hospital • In surgery, improvement was required to fully embed NHS Foundation Trust under the new methodology. We the World Health Organisation safer surgery have rated the hospital as good overall, accounting for checklist, in terms of both documentation and the the delivery model of care and the large volume of quality and staff engagement in the process. activity which takes place at the City Road Hospital site. • Some clinic waiting areas were extremely warm at We carried out an announced inspection between 9 - 13 times and, although temperature monitoring took May 2016. We also undertook unannounced visits during place, actions did not fully address the heat.
    [Show full text]
  • Barts Health NHS Trust Case Study
    Barts Health NHS Trust Case Study Rationalising three different LIMS into a single WinPath Enterprise solution for Barts Health NHS Trust THE CHALLENGE THE OUTCOMES CUSTOMER PROFILE To enable pathology across four Unified methodologies across all 26 million tests per year hospitals to work together hospitals and laboratories in the collaboratively and provide an network, delivering improved 27 labs over 5 sites enhanced service for clinicians, patient care through better offering patients access to a turnaround times, standard 600 staff centre of excellence reference ranges and optimised One of the largest NHS incorporating all aspects of a workflows, in line with the Carter quality pathology service. Report. Trusts Barts Health NHS Trust has one of the largest pathology units in the country, with over 600 staff performing more than 26 million tests per year – the equivalent of 2.5% of the total NHS pathology workload. Barts Health Pathology service is a comprehensive UKAS accredited pathology provider, occupying a purpose built facility located at the Royal London Hospital. They currently operate from four major hospital sites (Royal London, St Bartholomew’s, Whipps Cross and Newham) and at satellite locations (Mile End hospital). The service has been configured as a hub and spoke model and offers a wide repertoire of specialist services, including the main pathology disciplines, Clinical Transplantation, Molecular Haematology, Retinoblastoma, Flow Cytometry and Genomics. CliniSys’ WinPath LIMS has been an enduring part of the pathology
    [Show full text]
  • North Central & East London Foundation School Prospectus
    North Central & East London Foundation School Prospectus Programmes Commencing in August 2020 ______________ North Central and East London Foundation School: Programmes Commencing in August 2020 Introduction Welcome The North Central and East London (NCEL) Foundation School covers a diverse cultural and socio- economic area from Hampstead and Barnet in the west to Romford, Essex in the east. There are posts in 11 acute hospitals (7 NHS Trusts) and 4 mental health Trusts giving a range of opportunities for training. This prospectus should provide you with all the information you require when considering foundation training in north central and east London We hope you find it useful. Additional information is on our website: lonkssfoundation.hee.nhs.uk/ncelfs Deputy Director NCELFS Team Dr Celia Bielawski Director Dr Keren Davies Dr Celia Bielawski trained at Kings College Hospital Medical School and works as a consultant geriatrician and physician at Whittington Hospital. At Whittington she has held various education roles, including undergraduate sub dean, Foundation Keren Davies qualified from Leeds University Medical Training Programme director and Director of School in 1981. She was a Consultant Geriatrician at Postgraduate Medical Education. Barts Health for 25 years with a strong interest in As well as being Deputy Director of North Central & post graduate education East London Foundation School, appointed August She has held a number of posts in postgraduate 2018, she is a censor at The Royal College of education including Clinical tutor, Royal College tutor, Physicians. Training Programme Director for core medical training and lead Training programme Director for Geriatric medicine. She took up the post of training programme director Foundation training in 2007 before being appointed as Foundation Director for NETFS and subsequently, following the merger of schools in north central and east London, Director of the combined school.
    [Show full text]
  • Trust Name Hospital Name
    Trust Name Hospital Name Alder Hey Children's NHS Foundation Trust Alder Hey Children's Hospital Chepstow Community Hospital County Hospital, Griffithstown Maindiff Court Hospital Mamhalid (External Procurement Department) Monnow Vale Health and Social Care Centre Nevill Hall Hospital Redwood Suite, Rhymney Aneurin Bevan University Health Board Rhymney Integrated Health & Social Care Centre Royal Gwent Hospital St Cadoc's Hospital St Woolos Hospital The Grange University Hospital Ysbyty Ystrad Fawr Ysbyty'r tri Chwm Ashford Hospital Ashford and St Peter's Hospitals NHS Foundation Trust St Peter's Hospital King George Hospital Barking, Havering and Redbridge University Hospitals NHS Trust Queen's Hospital Barking Birth Centre Mile End Hospital Newham University Hospital Canary Wharf St Bartholomew's Hospital Barts Health NHS Trust The Barkantine Birth Centre The Dental Hospital The Royal London Hospital Trust Headquarters Whipps Cross University Hospital Bedfordshire Hospitals NHS Foundation Trust Bedford Hospital Birmingham Children's Hospital Birmingham Women's and Children's NHS Foundation Trust Birmingham Women's Hospital Bolton NHS Foundation Trust Royal Bolton Hospital Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Ely Day Surgery Unit The Rosie Hospital Macclesfield District General Hospital East Cheshire NHS Trust Congleton War Memorial Hospital Knutsford and District Community Hospital Kent and Canterbury Hospital Queen Elizabeth The Queen Mother Hospital East Kent Hospitals University NHS Foundation
    [Show full text]